Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination

Richard B. Lipton; M. E. Bigal; K. B. Kolodner; P. B. Gorelick; K. Wilks; M. Schoebelock; G. Davidai

doi:10.1212/01.WNL.0000138494.66691.07

Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination

Richard B. Lipton, M. E. Bigal, K. B. Kolodner, P. B. Gorelick, K. Wilks, M. Schoebelock, G. Davidai

Neurology

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7% of the participants developed headaches. The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.

Original language	English (US)
Pages (from-to)	1099-1101
Number of pages	3
Journal	Neurology
Volume	63
Issue number	6
DOIs	https://doi.org/10.1212/01.WNL.0000138494.66691.07
State	Published - Sep 29 2004

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/01.WNL.0000138494.66691.07

Fingerprint Dive into the research topics of 'Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination'. Together they form a unique fingerprint.

Cite this

@article{683bfa10c49b4b2381ce212b11595d23,

title = "Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination",

abstract = "The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7% of the participants developed headaches. The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.",

author = "Lipton, {Richard B.} and Bigal, {M. E.} and Kolodner, {K. B.} and Gorelick, {P. B.} and K. Wilks and M. Schoebelock and G. Davidai",

year = "2004",

month = sep,

day = "29",

doi = "10.1212/01.WNL.0000138494.66691.07",

language = "English (US)",

volume = "63",

pages = "1099--1101",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination

AU - Lipton, Richard B.

AU - Bigal, M. E.

AU - Kolodner, K. B.

AU - Gorelick, P. B.

AU - Wilks, K.

AU - Schoebelock, M.

AU - Davidai, G.

PY - 2004/9/29

Y1 - 2004/9/29

N2 - The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7% of the participants developed headaches. The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.

AB - The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7% of the participants developed headaches. The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.

UR - http://www.scopus.com/inward/record.url?scp=4644266898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644266898&partnerID=8YFLogxK

U2 - 10.1212/01.WNL.0000138494.66691.07

DO - 10.1212/01.WNL.0000138494.66691.07

M3 - Article

C2 - 15452309

AN - SCOPUS:4644266898

VL - 63

SP - 1099

EP - 1101

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 6

ER -